Arch Therapeutics, Inc. (OTCQB:ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care.
Discovery Life Sciences
3 followers
Mineralys Therapeutics
3 followers
Curi Bio
3 followers
Capricor Therapeutics
2 followers
Immunome
2 followers
Apogee Therapeutics
2 followers
PepGen
2 followers
Avalyn Pharma
2 followers
Kyverna Therapeutics
7 followers
Immunic Therapeutics
1 follower
ArriVent Biopharma
1 follower
Gloucester Marine Genomics Institute
1 follower